Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma

@inproceedings{Wu2018ExpressionPA,
  title={Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma},
  author={Fan Wu and Zheng Zhao and Ruichao Chai and Yuqing Liu and Kuanyu Wang and Zhiliang Wang and Guanzhang Li and Ruoyu Huang and Haoyu Jiang and Kenan Zhang},
  booktitle={Cancer Cell International},
  year={2018}
}
Increasing evidence has shown that long non-coding RNAs (lncRNAs) are important prognostic biomarkers and epigenetic regulators with critical roles in cancer initiation and progression. However, the expression and clinical prognostic value of antisense lncRNAs in diffuse glioma patients remain unknown. Here, we profiled differentially expressed antisense lncRNAs in glioma using RNA sequencing data from Chinese Glioma Genome Atlas database. Cox regression was performed to evaluate the prognostic… CONTINUE READING
BETA
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

Tumor Purity as an Underlying Key Factor in Glioma.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2017

Similar Papers

Loading similar papers…